New research presented at Heart Rhythm 2013 continues to show promising results for focal impulse and rotor modulation (FIRM) mapping to effectively target atrial fibrillation (AF) sources and...
Boston Scientific Corporation completed a first-in-human clinical trial utilizing the IntellaTip MiFi XP Ablation Catheter for the treatment of type 1 atrial flutter, an arrhythmia originating in...
New study data released at the Heart Rhythm Society (HRS) meeting last week validates the importance of contact force technology focused on improving the efficacy and safety of catheter...
nContact Inc. said it received conditional approval for an investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA) to begin enrollment in the CONVERGE...
Biosense Webster Inc. announced the 12-month safety and effectiveness results of the Thermocool Smarttouch catheter and software module in the treatment of symptomatic, drug refractory, paroxysmal...
Biosense Webster Inc. announced the first patient has been enrolled in the reMARQable clinical study. ReMARQable will assess the safety and efficacy of the use of the nMARQ Pulmonary Vein...
CardioFocus Inc. announced that as of late 2012, more than 1,000 clinical cases have been performed worldwide using the HeartLight technology. The company hosted an expert symposium to review the...
Endosense has announced that the results of its EFFICAS I prospective multi-center study have led to the development of guidelines for target and minimum contact force (CF), as well as minimum...
To help identify trends and find out what DAIC readers are interested in, the magazine takes note of what they click on when visiting the website. Below are the top 25 stories from 2012, and the...
The first patient has been treated in the Boston Scientific Corporation ZERO AF clinical trial to evaluate the safety and effectiveness of the Blazer open-irrigated temperature ablation Catheter...
nContact Inc. announced that the U.S. Food and Drug Administration (FDA) has cleared the Company’s modifications to its VisiTrax cardiac ablation device, EPi-Sense, now with embedded sensing...
October 19, 2012 — Boston Scientific Corp. entered into a definitive agreement to acquire privately-held Rhythmia Medical Inc., a developer of next-generation...
September 19, 2012 — This past week, surgeons and cardiologists at Sentara Heart Hospital were the first in the world to begin performing surgeries in the Dual Epicardial...
September 11, 2012 — St. Jude Medical Inc. announced the realignment of its product divisions into two new operating units: the Implantable Electronic Systems Division (IESD) and the...
August 20, 2012 — The Baylor Heart Hospital in Plano, Texas, recently became the first hospital in the world to merge two highly advanced technologies for...
Biosense Webster Inc. launched the new Carto 3 MEM (Multi-Electrode Mapping) Version in the United States. It is the latest advancement on the Carto 3 system platform.
July 26, 2012 — A new study shows promising data for a new method to image the source of atrial fibrillation (AF) and target its ablation to greatly reduce procedure time and substantially improve...
June 18, 2012 — Epicardial ablation device maker Contact Inc. announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary...
June 15, 2012 —Endosense,a pioneer and leader in force-sensing technology focused on improving the efficacy and safety of catheter ablation for the treatment of cardiac arrhythmias,...
June 15, 2012 — Cardiosolutions Inc. announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Dexterity Steerable Introducer, a next-generation...
The latest trends and newest cardiac rhythm management technology were highlighted during the biggest electrophysiology (EP) meeting in the world, Heart Rhythm Society (HRS) 2012 in May, held in...
May 24, 2012 —Advanced Cardiac Therapeutics Inc., a developer of temperature-sensing cardiac ablation systems, today announced results of several studies related to the company’s Tempasure cardiac...
May 24, 2012 -- nContact Inc., a provider of epicardial ablation devices, announced that new long-term physician data demonstrated promising clinical outcomes for the multidisciplinary...
A new electromapping technique can better visualize the rotor (similar to the eye of a hurricane) around which atrial fibrillation electrical activity rotates. Using this map, the...
May 14, 2012 – Endosense said there has been strong interest and significant advancement in the move toward making contact-force sensing a standard-of-care in ...
The new irrigated ablation catheter combines Biosense Webster’s latest porous tip technology with the accurate visualization of the Carto3 3-D mapping and ablation system. This enhanced technology...
May 9, 2012 — Sound Interventions Inc. announced the successful completion of the company's first-in-human clinical trial to treat resistant hypertension, SOUND-ITV.
ReCor Medical disclosed updated data for the REDUCE First-In-Man clinical study of its CE-marked Paradise (percutaneous renal denervation system) ultrasound platform, which is...
March 16, 2012 — Boston Scientific Corp. announced Health Canada approval of the Blazer open-irrigated catheter, the company's latest radiofrequency ablation (RFA) catheter designed to treat a...
The Heart Rhythm Society (HRS) issued an international consensus statement on indications, techniques and outcomes of catheter and surgical ablation of atrial fibrillation (AF).
February 28, 2012 — nContact Inc. announced a new preclinical study examining a unique minimally invasive percutaneous approach to accessing the heart that may enable electrophysiologists (EPs) to...
February 24, 2012 — CardioFocus Inc., developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF), announced the first patient has been enrolled and...
February 20, 2012 — ReCor Medical announced that its Paradise percutaneous ultrasound renal denervation system for achieving rhas received the CE mark. Paradise is designed to treat patients with...
February 15, 2012 — Vessix Vascular Inc., developer of a novel percutaneous radiofrequency (RF) balloon catheter technology, announced that it will make its first detailed public presentation of...
February 6, 2012 — Vascular Solutions Inc. announced it is marketing a reprocessing service for the ClosureFAST radiofrequency ablation catheter in the United States
February 3, 2012 – The U.S. Food and Drug Administration (FDA) approved the premarket approval application (PMA) for the St. Jude Medical Therapy Cool Path Duo and Satire BLU Duo ablation...
February 2, 2012 — Aria Health, the largest healthcare provider in Northeast Philadelphia and Bucks County, is the first on the East Coast to utilize Epoch, the latest generation of the...
January 25, 2012 — CardioFocus, Inc. developer of the HeartLight Endoscopic Ablation System (EAS) for the treatment of atrial fibrillation (AF) announced that a new study in the Journal of...
January 18, 2011 – Epicardial ablation device vendor nContact Inc. said data presented by physicians in two posters at the 17th Annual International Boston...
January 16, 2012 — Endosense has announced the European launch of the TactiCath 75 force-sensing ablation catheter as well as results of the EFFICAS clinical study of contact force-sensing in...
January 3, 2012 – Novadaq Technologies Inc., a developer of real-time imaging systems for use in the operating room, and Maquet Cardiovascular, a manufacturer of products for cardiac surgery...
December 12, 2011 – Hansen Medical UK Ltd., a subsidiary of Hansen Medical Inc., a developer of robotic technology for accurate 3-D control of catheter movement, announced a new multi-center...
December 5, 2011 – New study shows significant increase in quality of life (QoL) among overweight patients following ablation of atrial fibrillation (AF), compared to patients with a lower body...
October 14, 2011 – CardioFocus Inc., developer of the HeartLight endoscopic ablation system (EAS) for the treatment of atrial fibrillation (AF), announced that its HeartLight EAS was used to...
August 24, 2011 — CardioFocus Inc., developer of the HeartLight endoscopic ablation system (EAS) for the treatment of atrial fibrillation (AF), announced the system is now available in the United...
August 23, 2011 — nContact Inc. has received CE Mark approval for the EPi-Sense Guided Coagulation Device with VisiTrax for the treatment of cardiac arrhythmias, including atrial fibrillation (AF...
August 2, 2011 — St. Jude Medical Inc. today announced the first patient was enrolled in the EAST (Early comprehensive Atrial fibrillation Stroke prevention Trial) clinical trial.
July 18, 2011 — An article published in the European Journal of Cardio-Thoracic Surgery demonstrates the importance of a comprehensive epicardial lesion pattern to confirm conduction...
July 14, 2011 – Endosense, a Swiss medical technology company, has announced completion of the first patient case utilizing prototype software that integrates the contact-force data provided by...
July 13, 2011 – Many children and teens suffering from tachycardia, or rapid heart rate, have relied on medication to regulate their heart rhythms and control symptoms such as fatigue, dizziness and...
Research being presented at Society of Nuclear Medicine’s (SNM) 58th annual meeting shows that molecular imaging is helping to identify and treat a silent killer. A study focusing on hypertrophic...
May 6, 2011 – Rhythmia Medical Inc. and Endosense have engaged in a joint development project to integrate the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter...
May 4, 2011 – Endosense and Siemens Healthcare have completed a prototype software software software integrating the contact-force data provided by Endosense’s TactiCath force-sensing ablation...
May 3, 2011 – European CE mark approval was granted and the first use announced for the Blazer open-irrigated radiofrequency (RF) ablation catheter. The Boston Scientific catheter is designed to...
April 14, 2011 – Varicose veins are more than just a cosmetic consideration—they can cause pain and discomfort. Treating enlarged leg veins can relieve these problems and prevent complications in...
March 14, 2011 – Doctors at Beaumont Hospital in Troy, Mich., have performed the state’s first minimally invasive robotic procedure to correct atrial fibrillation. The new robotic maze procedure...
February 16, 2011 – Enrollment has been completed for a trial investigating a force-sensitive catheter during cardiac ablation. The EFFICAS study in intended to demonstrate that the TactiCath...
February 7, 2011 – There is a tremendous unmet need for new medical technologies to treat potentially dangerous chronic venous insufficiency (CVI) and blood clots, according to a Scientia Advisors...
January 27, 2011 – The first U.S.-procedure to use a new open-irrigated catheter was completed as part of the BLOCk-CTI trial. The study is using Boston Scientific’s Blazer Open-Irrigated Catheter...
January 19, 2011 – Siemens Healthcare is partnering with Endosense for the integration of the contact-force data provided by Endosense’s TactiCath force-sensing ablation catheter with Siemens’...
January 13, 2011 – The first patients have been enrolled in a trial evaluating the effectiveness and safety of a force-sensing ablation catheter for treating symptomatic paroxysmal atrial...
January 13, 2011 – St. Joseph's Hospital in Tampa, Fla., and the Baylor Jack and Jane Hamilton Heart and Vascular Hospital in Dallas, Texas, are among the first U.S. hospitals to treat patients...
January 13, 2011 – A new robotic navigation system has both received the CE mark and undergone its first successful cardiac ablation procedure. The Vdrive robotic navigation system, from...
January 11, 2011 - nContact Surgical, a cardiac ablation device manufacturer, is changing its name to nContact to reflect the trend away from surgery toward percutaneous and minimally invasive...
December 3, 2010 – The initial patients have been enrolled in a trial for treating atrial fibrillation (AF). The DEEP AF trial will evaluate the safety and efficacy of a dual epicardial/...
November 22, 2010 – Data presented at the American Heart Association’s Scientific Sessions 2010 showed that percutaneous renal nerve ablation reduces blood pressure. The data, which was also...
November 17, 2010 – Atrial fibrillation (AFib) patients treated with catheter ablation reported fewer symptoms and improved quality of life, according to data from Circulation Cardiovascular...
September 27, 2010 - Treating varicose veins with a new access kit reduces the number of steps and reduces procedure time. The .018-inch nitinol long-access wire for the VenaCure EVLT system, by...
September 7, 2010 - With increasing rates of patients with atrial fibrillation program suffering from severe strokes, medical associations fear an epidemic. New developments in minimally invasive...
September 2, 2010 – New research released this week is the first to find both anatomical and procedural considerations that can lead to the creation of esophageal ulcerations (ESUL) after...
